AIM
CYTK icon

Assured Investment Management’s Cytokinetics CYTK Stock Holding History

Assured Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,886
Closed -$49K – 1192
2018
Q2 		$49K Sell
5,886
-12,836
-69% -$107K ﹤0.01% 1114
2018
Q1 		$135K Buy
+18,722
New +$161K ﹤0.01% 1034

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Assured Investment Management's CYTK Position: Q3 2018 in Review

Assured Investment Management sold out of Cytokinetics (CYTK) in Q3 2018, closing a stake of 5,886 shares — an estimated $49K sold.

Assured Investment Management first reported a position in CYTK in Q1 2018 and held it in 2 quarters. The position peaked at $135K in Q1 2018. 122 funds tracked by Wall St. Rank hold CYTK as of Q3 2018.

  • Assured Investment Management reported no remaining Cytokinetics position as of Q3 2018 after selling out during the quarter.
  • Assured Investment Management sold 5,886 Cytokinetics shares in Q3 2018, an estimated $49K.
  • Assured Investment Management first reported a position in Cytokinetics in Q1 2018 and held it in 2 quarters.
  • Assured Investment Management's Cytokinetics position peaked at $135K in Q1 2018.
  • 122 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2018.

Based on Assured Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.